Earning Preview: Houlihan Lokey this quarter’s revenue is expected to decrease by 4.24%, and institutional views are mostly Buy

Earnings Agent10-21

Abstract

Houlihan Lokey will report fiscal second-quarter results on October 28, 2026 Post-Mkt, with investor attention centering on revenue, earnings trajectory, and segment mix after a weaker prior quarter and conservative near-term forecasts.

Market Forecast

Consensus forecasts for the current quarter point to revenue of 620.68 million US dollars and adjusted EPS of 1.66, implying year-over-year declines of 4.24% for revenue and 2.31% for adjusted EPS, alongside an EBIT estimate of 162.54 million US dollars, up 0.20% year-over-year. Forecast gross margin and net margin are not specified, but the mix implied by segment contributions suggests modest operational leverage if activity skews toward higher-fee assignments.

The main business is expected to be supported by steady advisory mandates, with Corporate Finance remaining the largest revenue contributor while Valuation Advisory maintains consistency and Restructuring offers a counter-cyclical buffer. The most promising segment is Financial Restructuring, with last quarter revenue at 119.00 million US dollars and multiple analyst references to resilience and pipeline strength into the current quarter.

Last Quarter Review

Houlihan Lokey reported revenue of 511.00 million US dollars, a gross profit margin of 92.56%, GAAP net profit attributable to the parent company of 78.00 million US dollars, a net profit margin of 15.26%, and adjusted EPS of 1.35, reflecting year-over-year declines of 15.59% for revenue and 36.92% for adjusted EPS. Sequentially, net profit fell by 21.87%, consistent with a quarter that saw fewer large fee events and a cautious client backdrop.

The quarter’s financial highlight was the resilience of unit-level margins despite top-line pressure, with gross margin staying high at 92.56%, indicating solid fee capture and a tight cost base even as revenue softened. Main business highlights included Corporate Finance contributing 303.00 million US dollars, Financial Restructuring generating 119.00 million US dollars, and Financial and Valuation Advisory delivering 89.00 million US dollars, reflecting a mix where advisory breadth helps stabilize earnings against cyclical swings.

Current Quarter Outlook

Corporate Finance Outlook

Corporate Finance remains the core revenue engine, and quarter-to-date expectations imply a moderate pace of closings relative to the prior year. The revenue estimate of 620.68 million US dollars for the firm, down 4.24% year-over-year, signals that deal conversion likely remains balanced rather than accelerating, with fee events concentrated but not broadly expanding. The near-term trend could be characterized by more selective transaction flow, where execution quality remains high but the volume of larger, fee-rich closings trails last year’s pattern.

In this setup, pricing discipline and mandate selection are essential for preserving margin quality while avoiding overextension into lower-fee assignments. The high gross margin profile demonstrated last quarter suggests the company can maintain advisory economics even when revenues are pressured, provided utilization stays healthy and staffing remains matched to live mandates. If a handful of larger transactions close late in the quarter, upside risk to revenue and EBIT could materialize, but the base case assumes steady rather than outsized conversion.

Financial Restructuring Outlook

Financial Restructuring stands out as the most promising segment into the print, with last quarter revenue of 119.00 million US dollars and multiple analysts citing franchise strength and durable assignment activity. The segment often provides stability during periods of slower transactional activity in other advisory lines, and recent analyst commentary points to momentum that could cushion firmwide performance. That backdrop aligns with the EBIT forecast showing a 0.20% year-over-year increase, suggesting operational resilience even as total revenue is expected to decline.

Pipeline development and phase progression within restructuring mandates matter: once mandates are secured, fee recognition typically follows milestone-based pacing, giving visibility despite timing variability across engagements. If restructuring assignments continue to advance and expand in scope, the segment could deliver relative outperformance and support consolidated earnings. This dynamic may help explain consensus expectations for a relatively modest EPS decline of 2.31% year-over-year despite anticipated top-line softness.

Stock Price Drivers This Quarter

The key near-term stock driver is the balance between realized fee events and the mix of assignments, which influences both revenue and operating leverage. A revenue outcome near 620.68 million US dollars alongside adjusted EPS around 1.66 would likely affirm consensus assumptions, while any skew toward larger closings or accelerated mandate conversion could drive an upside surprise. Conversely, a shortfall tied to delayed closings or softer-than-anticipated advisory activity would amplify the revenue decline and could compress earnings more than the expected 2.31% year-over-year.

Margin commentary will be closely watched, especially any signals on compensation ratios, utilization, and the sustainability of gross margin around the 90%-plus mark. Management’s discussion of backlog quality, the health of signed mandates, and the rate of conversion into fee events will inform whether the base case of cautious activity should be revised. Capital allocation updates, including potential adjustments to buybacks or dividends, may also influence sentiment if earnings visibility improves or if management elects to return more cash to shareholders.

Analyst Opinions

Bullish views dominate the collected opinions, with a ratio of bullish to bearish at 3:0 among the most recent published calls, and neutral stances not altering the prevailing positive skew. Goldman Sachs maintained a Buy rating with a price target of 152.00 US dollars, citing strength in the global restructuring franchise and its capacity to support near-term results. Keefe, Bruyette & Woods reiterated a Buy rating and set a price target of 172.00 US dollars, pointing to earnings durability and the potential for restructuring activity to mitigate variability in advisory fee timing.

BofA Securities maintained a Buy rating while adjusting its price target to 150.00 US dollars, noting the company’s consistent advisory economics and a resilient mandate pipeline that should help bridge cyclical slowdowns in certain transaction categories. Taken together, these bullish stances infer confidence in earnings stability even as revenue expectations lean conservative; the slight year-over-year EBIT growth implied by consensus corresponds to the view that operational execution remains sound. Importantly, the focus within these opinions is on the breadth of advisory capabilities and the ability to capture fees across market conditions, with particular emphasis on restructuring assignments as a stabilizing force.

Analysts also highlight that last quarter’s revenue and EPS misses were largely a function of timing rather than structural weakness, reinforcing the expectation that near-term results can normalize as mandates progress. With adjusted EPS forecast to be 1.66 and revenue projected at 620.68 million US dollars, the bullish camp anticipates a print that confirms cautious consensus without undermining the longer-term earnings path. Should management provide clearer visibility on backlog conversion and maintain a high gross margin profile, these price targets imply that upside depends less on a rapid rebound in overall transaction activity and more on consistent delivery across the advisory portfolio.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment